ABL Bio Market Cap

ABL Bio has a market cap or net worth of 10.51 trillion as of December 5, 2025. Its market cap has increased by 484.69% in one year.

Market Cap

10.51T

Enterprise Value

10.42T

Revenue

88.44B

Ranking

n/a

PE Ratio

n/a

Stock Price

190,600.00

Market Cap Chart

Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 10.51T, an increase of 1,626.36%. That is a compound annual growth rate of 50.51%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	10.51T	627.81%
Dec 30, 2024	1,443.63B	22.53%
Dec 28, 2023	1,178.16B	7.19%
Dec 29, 2022	1,099.13B	5.54%
Dec 30, 2021	1,041.42B	-27.59%
Dec 30, 2020	1,438.26B	31.46%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	75.96T
Celltrion	40.11T
ALTEOGEN	24.41T
SK Biopharmaceuticals	10.49T
Yuhan	8,755.13B
LigaChem Biosciences	6,753.15B
Peptron	6,645.44B
HLB Co., Ltd.	6,460.44B

Market Cap Rankings